Daniel G. Eramian
2012
In 2012, Daniel G. Eramian earned a total compensation of $745.4K as Former Executive Vice President Corporate Communications at CTI BioPharma, a 38% decrease compared to previous year.
Compensation breakdown
| Bonus | $37,800 |
|---|---|
| Salary | $275,625 |
| Stock Awards | $395,518 |
| Other | $36,424 |
| Total | $745,367 |
Eramian received $395.5K in stock awards, accounting for 53% of the total pay in 2012.
Eramian also received $37.8K in bonus, $275.6K in salary and $36.4K in other compensation.
Rankings
In 2012, Daniel G. Eramian's compensation ranked 7,316th out of 11,487 executives tracked by ExecPay. In other words, Eramian earned more than 36.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,316 out of 11,487 | 36th |
Division Manufacturing | 2,625 out of 4,253 | 38th |
Major group Chemicals And Allied Products | 674 out of 1,198 | 44th |
Industry group Drugs | 468 out of 920 | 49th |
Industry Pharmaceutical Preparations | 369 out of 700 | 47th |
Source: SEC filing on May 13, 2013.
Eramian's colleagues
We found seven more compensation records of executives who worked with Daniel G. Eramian at CTI BioPharma in 2012.
2012
James Bianco
CTI BioPharma
Chief Executive Officer
2012
Craig Philips
CTI BioPharma
Former President
2012
Jack Singer
CTI BioPharma
Chief Scientific Officer
2012
Louis Bianco
CTI BioPharma
Executive Vice President, Finance and Administration
2012
Steven Benner
CTI BioPharma
Chief Medical Officer
2012
Translational Benner
CTI BioPharma
Chief Medical Officer
2012
Matthew Plunkett
CTI BioPharma